Health
China’s CAS COVID-19 vaccine induces immune response in mid-stage tests – Reuters
A coronavirus vaccine candidate developed by the Chinese Academy of Sciences (CAS) was found to be safe and triggered immune responses in early and mid-stage trials,…
By Reuters Staff
BEIJING (Reuters) – A coronavirus vaccine candidate developed by the Chinese Academy of Sciences (CAS) was found to be safe and triggered immune responses in early and mid-stage trials, researchers said on Tuesday.
FILE PHOTO: The word “COVID-19” is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
A late-stage trial of the ZF2001 vaccine, which CAS is developing with a unit of Chongqing Zhifei Biological…
-
General10 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News19 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News9 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
Noosa News12 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland